5 reports

TABLE ##: ABEONA THERAPEUTICS PRODUCT PIPELINE BUSINESS OVERVIEW Oxford Biomedica Oxford Biomedica is a cell and gene based biopharmaceutical company headquartered in UK.

  • Biopharmaceutical
  • Gene Therapy
  • Therapy
  • Boehringer Ingelheim GmbH
  • Sangamo BioSciences, Inc.
  • PIPELINE PRODUCTS COVERED
  • Executive Summary

Despite its promise, its high price meant the drug was only used on one patient before being discontinued by its developer, UniQure BioPharma.

  • Biopharmaceutical
  • Gene Therapy
  • Medical Biotechnology
  • Therapy
  • Sangamo BioSciences, Inc.
  • APPROVALS (2015-2016)
  • DATE

PHONE: +##-##-##-## FAX: +##-##-##-## WEBSITE: WWW. SANGAMO. COM ##. ##. ## OVERVIEW SANGAMO IS A CLINICAL STAGE BIOPHARMACEUTICAL COMPANY, FOUNDED IN 1995 AND IS HEADQUARTERED IN CALIFORNIA, U. S.

  • Biopharmaceutical
  • Genomics
  • Cellectis S.A.
  • Horizon Discovery
  • Sangamo BioSciences, Inc.
  • SANGAMO BIOSCIENCES RAISES USD72.5 MILLION IN PUBLIC OFFERING OF SHARES
  • Oct 02, 2017: Sangamo And Bioverativ Announce FDA Acceptance of IND Application For ST-400 - A Gene-Edited Cell Therapy Candidate - to Treat Beta-Thalassemia

Smith has over ## years of biopharmaceutical industry experience in the United States, Europe, Canada and Asia.

  • Biopharmaceutical
  • Therapy
  • United States
  • Company
  • Sangamo BioSciences, Inc.

(Sangamo) is a clinical stage biopharmaceutical company which focuses on the the research and development and commercialization of engineered DNA-binding proteins (ZFPs) for gene regulation and therapeutic genome editing.

  • Biopharmaceutical
  • Blood Disease
  • Research And Development
  • Therapy
  • Sangamo BioSciences, Inc.